Advertisement
The LipiScan(TM) Coronary Imaging System will be displayed in the "Emerging Technologies" section at booth # 2410. Schedule of InfraReDx Events at TCT 2009 are as follows:
Advertisement
Monday, September 21st
On behalf of Cardiovascular Research Foundation, Dr. James Muller, founder and CEO of InfraReDx, has been invited to participate as a guest speaker titled:
"Vulnerable Plaque: Emerging Directions for Diagnosis and Treatment: Near Infrared Spectroscopy I: Technology and validation."
Friday, September 25th
InfraReDx sponsored Breakfast Symposium:
"Beyond Angiography: NIR Spectroscopy and Other Methods for Plaque Characterization."
About InfraReDx, Inc.
InfraReDx, Inc., headquartered in Burlington, Massachusetts, was founded in 1998 and is a privately-funded medical device company developing a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. For more information, visit www.infraredx.com.
About TCT 2009
TCT is organized by the Cardiovascular Research Foundation, which is dedicated to research and education in the broad subspecialty of interventional cardiology and endovascular medicine. The TCT meeting is the primary annual meeting for the world-wide interventional cardiology community. For more information, visit www.tctconference.com
Company Contacts:
-- 2:40 pm in room # 130 at the Moscone Center.
SOURCE InfraReDx, Inc.
